A. Preti
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 7
- Oncology 6
- Cancer Treatment and Pharmacology 3
- Co-authors
- Fernando Cabanillas (11 shared papers)Hagop M. Kantarjian (3 shared papers)Jorge Romaguera (10 shared papers)Roberto Ferrarese (2 shared papers)Filippo Canducci (2 shared papers)Elisa Rita Ceresola (2 shared papers)Maria Alma Rodriguez (8 shared papers)Fredrick B. Hagemeister (7 shared papers)
- Journals
- Annals of Oncology (3 papers)Journal of Clinical Oncology (2 papers)British Journal of Haematology (2 papers)Clinical Infectious Diseases (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- United StatesItaly
In The Last Decade
A. Preti
17 papers receiving 581 citations
Peers
Comparison fields: 5 of 76
- Pathology and Forensic Medicine 262
- Genetics 100
- Oncology 173
- Hematology 63
- Gastroenterology 24
Countries citing papers authored by A. Preti
This map shows the geographic impact of A. Preti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Preti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Preti more than expected).
Fields of papers citing papers by A. Preti
This network shows the impact of papers produced by A. Preti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Preti. The network helps show where A. Preti may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Preti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 133 | |
| 2 | 2018 | 75 | |
| 3 | Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma. | 2000 | 52 |
| 4 | 1998 | 48 | |
| 5 | 1996 | 47 | |
| 6 | 2002 | 47 | |
| 7 | 1994 | 46 | |
| 8 | 1994 | 36 | |
| 9 | 1997 | 31 | |
| 10 | 2018 | 18 | |
| 11 | 1998 | 17 | |
| 12 | 1994 | 12 | |
| 13 | 1997 | 11 | |
| 14 | Characteristics and outcome of patients with acute lymphocytic leukemia and myeloperoxidase-positive blasts by electron microscopy. | 1994 | 11 |
| 15 | Paclitaxel (Taxol) for the treatment of lymphoma. | 1997 | 10 |
| 16 | 1999 | 5 | |
| 17 | 1997 | 5 |
About A. Preti
A. Preti is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Neurology and Public Health, Environmental and Occupational Health, having authored 17 papers that have together received 604 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (4 papers), CNS Lymphoma Diagnosis and Treatment (4 papers), Cancer Treatment and Pharmacology (3 papers), Acute Myeloid Leukemia Research (1 paper), Pneumocystis jirovecii pneumonia detection and treatment (1 paper) and Mycobacterium research and diagnosis (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (262 citations), Genetics (100 citations), Oncology (173 citations), Hematology (63 citations) and Gastroenterology (24 citations). A. Preti has collaborated with scholars based in United States and Italy. Frequent co-authors include Fernando Cabanillas, Hagop M. Kantarjian, Jorge Romaguera, Roberto Ferrarese, Filippo Canducci, Elisa Rita Ceresola, Maria Alma Rodriguez, Fredrick B. Hagemeister, Peter McLaughlin and A H Sarris. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, British Journal of Haematology, Clinical Infectious Diseases and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.